Medline Inc. beat EPS estimates 67% of the time across 3 reported quarters (2 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.30 | $0.47 | +56.7% | Beat |
| Q12026 FY2026 | $0.29 | $0.33 | +13.8% | Beat |
| Q42025 FY2025 | $0.24 | $-0.01 | -104.2% | Miss |
Back to MDLN overview · MDLN holders · MDLN KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.